The construct containing mouse glial fibrillary acidic protein (Gfap) promotor driving cre/ERT2 fusion gene was used to create a transgenic line in C57BL/6 mouse. Cre recombinase is activated in brain, lung, spleen, kidney, liver Harderian gland, stomach, and appendix after tamoxifen-induced.